Meet the team of contributing medical writers from Fox Chase Cancer Center who provide onsite reporting from major urologic oncology meetings and conferences.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Mohammed Haseebuddin, MD is currently a clinical fellow of urologic oncology and robotic surgery at Fox Chase Cancer Center in Philadelphia, PA. Dr. Haseebuddin graduated from Washington University School of Medicine from Saint Louis, MO in 2009. He then completed a general surgery and urology residency at Barnes Jewish Hospital/Washington University in Saint Louis, MO.
Nikhil Waingankar, MD completed his undergraduate studies at Northwestern University (Evanston, IL) and medical school at the University of Oklahoma College of Medicine (Oklahoma City, OK). He finished his urology residency training at North Shore-Long Island Jewish Health System (New Hyde Park, NY), and is currently a urologic oncology fellow at Fox Chase Cancer Center (Philadelphia, PA).
# # #
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA USA